| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.44B | 25.41B | 23.97B | 23.26B | 21.23B | 19.28B |
| Gross Profit | 9.19B | 9.72B | 9.11B | 8.78B | 8.03B | 7.63B |
| EBITDA | 1.70B | 1.93B | 1.83B | 1.92B | 1.51B | 1.32B |
| Net Income | 740.00M | 909.00M | 748.00M | 768.00M | 602.00M | 178.00M |
Balance Sheet | ||||||
| Total Assets | 20.52B | 24.14B | 19.66B | 18.93B | 16.58B | 15.11B |
| Cash, Cash Equivalents and Short-Term Investments | 2.26B | 3.83B | 1.77B | 1.57B | 1.08B | 904.00M |
| Total Debt | 7.57B | 10.17B | 7.29B | 6.75B | 6.56B | 5.43B |
| Total Liabilities | 13.30B | 16.21B | 12.43B | 12.29B | 10.95B | 10.00B |
| Stockholders Equity | 7.22B | 7.94B | 7.22B | 6.63B | 5.62B | 5.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.00M | -76.00M | 1.13B | -401.00M | 276.00M |
| Operating Cash Flow | 0.00 | 1.97B | 838.00M | 1.69B | 1.14B | 922.00M |
| Investing Cash Flow | 0.00 | -2.52B | -828.00M | -988.00M | -1.68B | -481.00M |
| Financing Cash Flow | 0.00 | 2.60B | 192.00M | -206.00M | 748.00M | -509.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥16.03B | 25.18 | ― | 2.11% | 5.82% | 75.66% | |
66 Neutral | ¥15.49B | -103.50 | ― | 1.48% | 5.48% | 9.22% | |
65 Neutral | ¥13.78B | 9.24 | ― | 1.43% | 5.88% | 180.90% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥10.72B | 23.12 | ― | 2.61% | 6.01% | 21.26% | |
53 Neutral | ¥16.07B | 74.17 | ― | ― | -0.33% | 155.36% | |
46 Neutral | ¥34.41B | 21.75 | ― | 1.65% | -1.17% | -95.57% |